Volume has been starting to build with this stock

MEDH Is Our Newest LOW FLOAT Breakout Play!

This Stock May Not Remain Under The Radar Much Longer!

Greetings Traders,

We have another top potential trading opportunity for you this afternoon that needs your immediate attention... hurry and load up MEDH.

MEDH is a low float stock that could potentially be a high percentage gainer for our readers.

This is our first alert to get June rolling and we're pretty excited about it. MEDH could be ready for an amazing bounce soon. The stock was trading as high as 90 cents just last week!

MEDH has an incredibly LOW FLOAT of just around 2.3 million shares. If you're unfamiliar with why this is signifcant, let us quickly explain.

The float of a stock is the amount of shares avaible for trading to the public. A low supply matched by an increased demand is what tends to send these kind of stocks through the roof.

With such a tiny float, you never know when MEDH could be ready to roar if it picks up market recognition..

Low float stocks are sometimes capable of moves in the 100's if not 1000's of PERCENTS!

This is a stock that could be a real diamond in the rough right now just waiting for Wall Street to discover it. Especially given the huge news the company had last month.

MEDH announced that it is in the process of becoming licensed as a Wholesale Distributor of Pharma in the state of Alabama. The company has also entered into an Exclusive Marketing Agreement with B&B Consulting whose sales exceeded over $7M in pharma sales last year!

THAT'S NOT AT ALL.. MEDH has also secured an agreement with one of the LARGEST FDA Manufacturers in the United States!

The company's first product that has been approved to sell is a 5% Lidocaine Ointment 50g jar. 5% Lidocaine is a highly sought after analgesic ointment for the purpose of reducing and controlling pain.

The overuse of oral prescription pain medication is a tragedy in this nation. We are in an opioid overdose epidemic!

Opioids (including prescription opioid pain relievers and heroin) killed more than 28,000 people in 2014. These rising deaths are making it necessary for physicians and other medical professionals to look at alternative solutions when treating pain.

With the demand for alternative pain medicine growing more robust, MEDH could be soon making a big splash with their Lidocaine ointment.

The company's new business plans are still very fresh but more of the market may soon be catching on. Start researching fast!

For more information on the company, visit: www.medxholdings.com

MEDH could be setting up for some scorching returns so keep this LOW FLOAT on your radar!

Disclaimer: Investors Hub Newswire has been paid $1,000 by Ninjanuity to disseminate this email.

Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Apr 2024 to May 2024